Principal Investigator
Henry Moore
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210142
Clinical Trial Summary
A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study inParkinsons Disease Patients With Dyskinesia to Assess the Efficacy andSafety/Tolerability of Fixed Dose Combinations of JM-010 and itsIndividual Components
Phase
Phase II
Funding Agency/Sponsor
Intramural
Disease
Movement Disorders
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu